Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than ' million visitors each month.

WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!




Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Archive
Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Search artcles published since 2007

November 9, 2012--------News Archive Return to: News Alerts

A rich network of blood vessels located in the brain, are responsible for the
production of cerebrospinal fluid (CSF), the fluid which surrounds and cushions
the brain and spinal cord. The choroid plexus and the arachnoid membrane act
together at the barriers between the blood and CSF.

The choroid plexus not only forms the CSF but also actively regulates its'
concentration of molecules. It is highly vascularized with cauliflower-like masses
of pia tissue that flow into pockets of ependymal cells. Most of the choroid plexus is
distributed throughout the fourth ventricle near the base of the brain and in the
lateral ventricles inside the right and left cerebral hemispheres.

WHO Child Growth Charts


New Cell Type Developed in Hope of Treating Alzheimer’s and Other Brain Diseases

UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer’s. The discovery accelerates efforts at the Sue & Bill Gross Stem Cell Research Center

Dr. Edwin Monuki of the University of California, Irvine (UCI) in the Sue & Bill Gross Stem Cell Research Center, along with developmental & cell biology graduate student Momoko Watanabe and colleagues developed these cells — choroid plexus epithelial cells (CPECs) — from existing mouse and human embryonic stem cell lines.

CPECs are critical for proper functioning of the choroid plexus, the tissue in the brain that produces cerebrospinal fluid (CSF). Among their various roles, CPECs make CSF and remove metabolic waste and foreign substances from the fluid and brain.

In neurodegenerative diseases, the choroid plexus
and choroid plexus epithelial cells (CPECs) age
prematurely, resulting in reduced cerebrospinal
fluid (CSF) formation and a decreased ability
to flush out debris such as the hallmark
plaque-forming proteins of Alzheimer’s.

Although transplant studies have provided proof
of concept for CPEC-based therapies, such therapies
have been held back by the inability to expand
or generate CPECs in culture.

“Our method is promising, because for the first time we can use stem cells to create large amounts of these epithelial cells, which could be utilized in different ways to treat neurodegenerative diseases,” said Monuki, an associate professor of pathology & laboratory medicine and developmental & cell biology at UCI.

The study appears in today’s issue of The Journal of Neuroscience.

To create the new cells, Monuki and his colleagues
coaxed embryonic stem cells to differentiate into
immature neural stem cells. They then developed
the immature cells into CPECs capable of
delivered to a patient’s choroid plexus.

These cells could be part of neurodegenerative disease treatments in at least three ways, Monuki says:

First, they’re able to increase the production of CSF
In order to help flush out plaque-causing proteins
from brain tissue and limit disease progression.

Second, CPEC “superpumps” could be designed to
transport high levels of therapeutic compounds to
the CSF, brain and spinal cord.

Third, CPEC cells can be used to screen and optimize
drugs that improve choroid plexus function.

Monuki said the next steps are to develop an effective drug screening system and to conduct proof-of-concept studies to see how CPECs affect the brain in mouse models of Huntington’s, Alzheimer’s and pediatric brain diseases.

Young-Jin Kang, Sanket Meghpara, Kimbley Lau, Chi-Yeh Chung and Jaymin Kathiriya of UCI and Anna-Katerina Hadjantonakis of the Sloan-Kettering Institute in New York contributed to the study, which received support from the National Institutes of Health (grant NS064587), the California Institute for Regenerative Medicine, UCI’s Institute for Clinical & Translational Science and UCI’s Alzheimer’s Disease Research Center.

About the University of California, Irvine: Founded in 1965, UCI is a top-ranked university dedicated to research, scholarship and community service. Led by Chancellor Michael Drake since 2005, UCI is among the most dynamic campuses in the University of California system, with nearly 28,000 undergraduate and graduate students, 1,100 faculty and 9,000 staff. Orange County’s second-largest employer, UCI contributes an annual economic impact of $4 billion. For more UCI news, visit www.today.uci.edu.

Original article:http://today.uci.edu/news/2012/11/nr_monuki_121107.php